Ticker Details
ADiTx Therapeutics, Inc.
IPO Date:	June 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$262.66K
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 6.31%
Avg Daily Range (30 D):	$0.04 | 7.96%
Avg Daily Range (90 D):	$0.08 | 8.15%

Institutional Daily Volume
Avg Daily Volume:	6.04M
Avg Daily Volume (30 D):	4.33M
Avg Daily Volume (90 D):	2.6M

Trade Size
Avg Trade Size (Sh.):	665
Avg Trade Size (Sh.) (30 D):	415
Avg Trade Size (Sh.) (90 D):	318

Institutional Trades
Total Institutional Trades:	23
Avg Institutional Trade:	$.7M
Avg Institutional Trade (30 D):	$.51M
Avg Institutional Trade (90 D):	$.51M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.99M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	188.17K

News

Dec 17, 2025 @ 1:26 PM Stock Market Today: S&P 500, Dow Futures Gain As J... Source: Rishabh Mishra

Nov 13, 2025 @ 9:05 PM Evofem Reports Financial Results for Third Quarter... Source: Prnewswire

Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire

Sep 11, 2025 @ 1:18 PM Evofem's "Say Vagina" Campaign Generates More than... Source: Prnewswire

Sep 9, 2025 @ 1:28 PM Evofem Anticipates Approval of Merger with Aditxt ... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-891.38	$-790.49	$451.34
Diluted EPS	$-891.38	$-790.49	$451.34
Revenue	$.01M	$.01M	$M
Gross Profit	$M	$M	$M
Net Income / Loss	$-53.02M	$-16.19M	$-5.23M
Operating Income / Loss	$-18.32M	$-4.36M	$-4.67M
Cost of Revenue	$.01M	$.01M	$M
Net Cash Flow	$-.56M	$-2.93M	$3.04M
PE Ratio

Splits
May 18, 2026	1:27
Mar 09, 2026	1:8
Nov 03, 2025	1:113
Mar 17, 2025	1:250
Oct 02, 2024	1:40
Aug 18, 2023	1:40
Sep 14, 2022	1:50